Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
Eagle Pharmaceuticals (Nasdaq: EGRX) announced that CEO Scott Tarriff and CFO Brian Cahill will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 4:30 p.m. EST. The presentation will be webcast live and archived for 30 days on the Company’s website under the Investors Section. Eagle is committed to developing innovative medicines, with commercialized products including RYANODEX®, BENDEKA®, and BELRAPZO®. For more information, visit www.eagleus.com.
- None.
- None.
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference as follows:
Date: |
Wednesday, January 13, 2021 |
|||
Time: |
4:30 p.m. Eastern Standard Time |
|||
Webcast: |
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005787/en/
FAQ
When is Eagle Pharmaceuticals presenting at the J.P. Morgan Healthcare Conference?
Where can I watch the Eagle Pharmaceuticals presentation?
Who will present for Eagle Pharmaceuticals at the conference?
What products does Eagle Pharmaceuticals offer?